My Most Difficult Choice | TIME
Heart attack, stroke or cancer. Take your pick. That was the choice I was being offered, or so it seemed. Im one of hundreds of patients who were participating in clinical trials to investigate whether COX-2 inhibitors such as Celebrex and Vioxx, commonly used as anti-inflammatory drugs, are also effective in fighting or preventing cancer.